These data strongly support that MAP4K4 is a critical regulator of SNO-Drp1 and that inhibiting MAP4K4 can suppress oxidative stress and ferroptosis, thus inhibiting the development of microcirculatory disturbance in DCM. Here, DNM1L is linked to familial dilated cardiomyopathy.